Cliff Asness's MAZE Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 0 shares of Maze Therapeutics, Inc. (MAZE) worth $0, representing 0.00% of the portfolio. First purchased in , this recently established position has been held for 0 quarters.
Based on recent 13F filings, Cliff Asness has initiated a new position in MAZE, representing a fresh investment thesis on this company. Largest addition occurred in Q3 2025, adding 148 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Maze Therapeutics (MAZE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Maze Therapeutics (MAZE) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| No data available | ||||
Cliff Asness's Maze Therapeutics Investment FAQs
According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 27,615 shares of Maze Therapeutics, Inc. (MAZE), valued at approximately $716,057.
As of the Q3 2025 filing, Maze Therapeutics, Inc. (MAZE) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Maze Therapeutics, Inc. (MAZE) was 27,615 shares, as reported at the end of Q3 2025.